<div><br />
</div><img alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/107053651_1786740261810457_r.png" width="100%" />
<div>In June 2024, Anita was diagnosed with cholangiocarcinoma, a rare and aggressive bile duct cancer. Since that day she has faced major liver surgery, round after round of chemotherapy, radiofrequency ablation, and radiation. Through every painful treatment she has remained gentle and strong. Still the cancer has continued to advance inside her liver. She has lost a devastating amount of weight and now fights constant nausea, repeated infections, deep fatigue, and pain every single day.
</div>
<div><br />
</div>
<div>Anita is a 47-year-old devoted teacher and the loving mother of an 8-year-old daughter who lights up her world. Two years ago, while heading home from work, she stopped for a simple ultrasound to check a kidney stone. That ordinary appointment uncovered something far more serious in her liver and quietly turned her family’s life upside down.
</div>
<div><br />
</div>
<div>For two long years her family has carried the full weight of her medical care on their own. They sold their car, sacrificed their business, and used everything they had, holding on to the hope that each new treatment would finally bring her peace. They never asked anyone for help until now. That hope now rests on targeted therapy and immunotherapy.
</div>
<div><br />
</div>
<div>Targeted therapy is a newer type of cancer treatment that works differently from traditional chemotherapy. Instead of attacking all fast-growing cells in the body, it is designed to identify and block specific changes or mutations inside the cancer cells that help them grow and spread. Immunotherapy works by helping Anita’s own immune system recognize and fight the cancer more effectively. Both approaches are more precise than standard chemotherapy and offer her the best remaining chance to control the disease and spend more time with her little girl.
</div>
<div><br />
</div>
<div>These advanced treatments are extremely expensive. The monthly cost of targeted therapy or immunotherapy often ranges from $1,500 to $3,000 or more. In addition to the medicines themselves, Anita will need regular hospital visits, blood tests, infection management, nutritional support, and other supportive care. The family is seeking to raise $50,000 to cover several months of treatment and essential medical care. This amount is far beyond what they can manage alone after already giving up so much.
</div>
<div><br />
</div>
<div>Your support will help provide:
</div>
<div>- Targeted therapy and immunotherapy medicines and related treatment costs
</div>
<div>- Hospital care, antibiotics, and relief from her symptoms
</div>
<div>- Nutritional support to help her regain strength
</div>
<div><br />
</div>
<div>Anita has met every hardship with quiet courage and grace. She is not only fighting for her own life. She is fighting to stay here for her daughter, to watch her grow, to hold her, and to continue being the mother her child needs. Even the smallest donation, and every time you share this campaign, carries real hope to a mother who has already given everything she has.
</div>
<div><br />
</div>
<div>Thank you for standing beside Anita and her family when they need it most.
</div>

Ellen Sirekanian

Anonymous

Help Anita Fight Advanced Bile Duct Cancer

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

currencyCode

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

writePath

Stream Notification

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

Influencer - Prod

US fundraisers and US users

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

userCurrencyCode

Localized Currency

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Help Anita Fight Advanced Bile Duct Cancer

Still $49,835 to go. Help us build momentum.